Turned family loss to stronger patient voice – with Simone Leyden

When Simone Leyden lost her 34 year old sister in a rare GI cancer she and her brother John decided to start a foundation. What struck them, when their sister was struggling, was that there was a huge difference in treatment and support for less common cancers, compared to more common ones. Please join us and listen to this episode of Theragnostic Talks Simone, founder and CEO of NeuroEndocrine Cancer.

Guest: Simone Leyden, co-founder and CEO NeuroEndocrine Cancer

By: Gustav Widar & Annette Andrén

Contact us: [email protected]

For more info, visit www.samnordic.se